Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEPOLIZUMAB vs MEPROBAMATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MEPOLIZUMAB vs MEPROBAMATE: Safety Overview

Metric MEPOLIZUMAB MEPROBAMATE
Total FAERS Reports 43,006 427
Deaths Reported 3,158 320
Death Rate 7.3% 74.9%
Hospitalizations 13,819 55
Average Patient Age 58.9 yrs 44.8 yrs
% Female Patients 67.1% 54.6%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer GlaxoSmithKline LLC Cipla USA Inc.
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Discontinued